Next-generation asthma inhalers

December 7, 2018, CORDIS
Next-generation asthma inhalers
Credit: Konstantinos Votis

In Europe alone, there are almost 30 million people who suffer from asthma. The myAirCoach project provides an innovative smart inhaler device along with integrated mobile Health (mHealth) personalised asthma monitoring services for empowering and guiding patients with asthma to manage their own health on a daily basis.

Asthma, a chronic inflammatory disease of the airways, is the most common disease of childhood, posing a significant socioeconomic burden. Although cannot be cured, its symptoms can be satisfyingly controlled to ensure the best quality of life for .

To address this issue, the EU-funded myAirCoach project proposed a novel mobile health tool so patients can manage their own health. "Our aim was to generate a personalised guidance system that empowers patients to optimise their treatment and manage asthma,″ explains Dr. Konstantinos Votis, a key researcher and technical coordinator in the project. The idea is for patients to gain control over this disease but also to adhere to personalised goals and guidelines such as a healthy lifestyle, exercise and specific dietary habits.

Innovative design

The myAirCoach comprises of a sensor-based inhaler capable of monitoring several clinical, behavioural and environmental factors, and communicating them to a mobile device. It incorporates user friendly tools and provides direct feedback to an appointed healthcare setting to ensure timely optimal treatment.

myAirCoach scientists developed a pipeline of advanced algorithms, and machine learning techniques. This involved the processing of raw physiological measurements such as exhaled nitric oxide, and such as humidity provided through wireless sensors. Using a computational modelling approach, behavioural variables such as physical activity are dynamically evaluated alongside personal profile data. This provides patients with personalised prediction to manage and reduce the risk of exacerbations in outdoor and indoor environments. It also recognises the treatment scheme and reminds patients to take medication while supporting them through each step of inhalation therapy. Collectively, the physiological information and the patient adherence to therapy are communicated to healthcare professionals.

A major challenge was the miniaturisation of sensors for their successful integration into the self-management framework. In addition, the smart inhaler had to become an integral part of the existing clinical procedures and asthma treatment protocols. When tested in patients, the system exhibited clinically relevant and statistically significant improvement in asthma control and reduction in severe asthma exacerbations.

Impact of the myAirCoach solution

myAirCoach is an improvement of existing self-management systems, which are complex in nature, and are based on the assumption that patients will commit to the self-management methodology.

Dr. Votis says, "myAirCoach has been designed to fill this commitment gap by introducing an intelligent sensing environment, thereby minimising patient intervention to the monitoring procedure.″ The most significant achievement is undoubtedly the personalised response to treatment and progress, which empowers patients to be active participants in their disease management.

Overall, the myAirCoach system is expected to optimise strategies for the treatment of asthma on a patient basis after taking into consideration disease progression and evolution. At the same time, healthcare professionals will be able to supervise the condition of patients outside the clinic and use analytical tools to support their treatment decision. The system will also be beneficial for families of asthma sufferers as they will be better informed about the clinical state of their loved ones and the proper use of medication.

Dr. Votis says, "The patented myAirCoach system to extend its application beyond asthma for the self-management of other respiratory diseases.″ Long term, this will translate into a better understanding of the mechanisms underpinning the onset and progression of these diseases.

Explore further: Research aims to drag asthma management into the 21st century

Related Stories

Research aims to drag asthma management into the 21st century

May 2, 2017
A new study by University of Manchester researchers, published today - World Asthma Day - has probed the features that both patients and healthcare professionals want from an asthma management app.

Smart inhaler to help asthma sufferers breathe easier

September 21, 2017
With almost 30 million people under the age of 45 living with asthma in Europe, new 'smart inhalers' may provide better ways of treating the disease and help scientists understand what is driving this growing global epidemic.

What treatable traits predict future asthma attacks?

September 19, 2018
Investigators have assessed the prevalence of treatable traits in severe asthma and have determined which specific traits are predictive of future asthma attacks. Their findings, which are published in Respirology, are the ...

Raising awareness about asthma is critical, says expert

May 15, 2018
Millions of people in the United States, regardless of age, gender, race and ethnicity, are impacted by asthma, and the number of asthma sufferers is only projected to grow. To raise awareness about this disease, May is recognized ...

New asthma tool determines best treatment for severe asthma patients

June 19, 2018
One in 12 adults and one in 11 children in the United States are living with asthma, according to the Centers for Disease Control and Prevention (CDC). The communication between patients and clinicians is an important factor ...

Have asthma and a pet? Re-homing your cat or dog may not be necessary

October 4, 2018
A study from the Nationwide Children's Hospital analyzed environmental exposures, like pet and secondhand smoke, to determine if they have a role in asthma control among children whose asthma is managed per NAEPP (EPR-3) ...

Recommended for you

Targeting sepsis, the leading cause of ICU deaths, with a nanocarrier-delivered microRNA

December 3, 2018
One in three patients who die in the U.S. dies of sepsis, according to the Centers for Disease Control and Prevention. It is one of the leading causes of death in intensive care units and, with an estimated price tag of $20 ...

Cells using sugar for metabolic process may fight inflammation

November 27, 2018
New research by a team from the FAMU-FSU College of Engineering has discovered that a type of adult stem cell found in a variety of tissues can be manipulated to enhance tissue regeneration and potentially treat inflammatory ...

To resolve inflammation, location matters

November 19, 2018
Health conditions that involve inflammation run the gamut, from multiple sclerosis and lupus to arthritis, diabetes, and cancer. While inflammation can serve as a normal response to help the body deal with injury or infection, ...

Patchy distribution of joint inflammation resolved

November 16, 2018
Chronic inflammatory rheumatic diseases such as rheumatoid arthritis (RA) and spondylo-arthritis (SpA) are chronic, disabling diseases with a poor outcome for loco-motoric function if left untreated. RA and SpA each affect ...

Discovery suggests new route to fight infection, disease

November 14, 2018
New research reveals how a single protein interferes with the immune system when exposed to the bacterium that causes Legionnaires' disease, findings that could have broad implications for development of medicines to fight ...

Can't exercise? A hot bath may help improve inflammation, metabolism, study suggests

November 14, 2018
Hot water treatment may help improve inflammation and blood sugar (glucose) levels in people who are unable to exercise, according to a new study. The findings are published ahead of print in the Journal of Applied Physiology.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.